Pancreatic injury induces β-cell regeneration in axolotl
- PMID: 40679186
- PMCID: PMC12412420
- DOI: 10.1002/dvdy.70060
Pancreatic injury induces β-cell regeneration in axolotl
Abstract
Background: Diabetes is a condition characterized by a loss of pancreatic β-cell function, which results in the dysregulation of insulin homeostasis. Using a partial pancreatectomy model in axolotl, we aimed to observe the pancreatic response to injury.
Results: Here we show a comprehensive histological characterization of pancreatic islets in axolotl. Following pancreatic injury, no apparent blastema-like structure was observed. We found a significant, organ-wide increase in cellular proliferation post-resection in the pancreas compared to sham-operated controls. This proliferative response was most robust at the site of injury. Further, an increase in nuclear density was observed, suggesting compensatory congestion as a mechanism of regeneration. We found that β-cells actively contributed to the increased rates of proliferation upon injury. β-Cell proliferation manifested in increased β-cell mass in injured tissue at 2 weeks post-injury. At 4 weeks post-injury, we found organ-wide proliferation to be extinguished while proliferation at the injury site persisted, corresponding to pancreatic tissue recovery. Similarly, total β-cell mass was comparable to sham after 4 weeks.
Conclusions: Our findings suggest a non-blastema-mediated regeneration process takes place in the pancreas, by which pancreatic resection induces whole-organ β-cell proliferation without the formation of a blastemal structure. This process is analogous to other models of compensatory congestion in axolotl.
Keywords: compensatory congestion; diabetes; insulin; pancreatectomy; proliferation; resection.
© 2025 American Association for Anatomy.
Conflict of interest statement
Declaration of Interests
JLW is a co-founder of Matice Biosciences. Other authors declare no competing interests.
Update of
-
Pancreatic injury induces β-cell regeneration in axolotl.bioRxiv [Preprint]. 2025 Jan 23:2025.01.23.634564. doi: 10.1101/2025.01.23.634564. bioRxiv. 2025. Update in: Dev Dyn. 2025 Jul 18. doi: 10.1002/dvdy.70060. PMID: 39896453 Free PMC article. Updated. Preprint.
References
-
- Vegas AJ, Veiseh O, Gürtler M, Millman JR, Pagliuca FW, Bader AR, Doloff JC, Li J, Chen M, Olejnik K, Tam HH, Jhunjhunwala S, Langan E, Aresta-Dasilva S, Gandham S, Mcgarrigle JJ, Bochenek MA, Hollister-Lock J, Oberholzer J, Greiner DL, Weir GC, Melton DA, Langer R, Anderson DG, 2016. Long-term glycemic control using polymer-encapsulated human stem cell–derived beta cells in immune-competent mice. Nature Medicine 22, 306–311.. 10.1038/nm.4030 - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
